• Profile
Close

Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy

American Journal of Reproductive Immunology Dec 07, 2017

Enninga EAL, et al. - Given a high involvement of soluble program death ligand-1 (sPD-L1) and galectin-9 in immune suppression during cancer, these molecules were assessed in the blood samples from pregnant women during gestation. Researchers noted that during pregnancy, immune-regulatory molecules galectin-9 and sPD-L1 increased. Furthermore, these molecules may play a role in immune tolerance that is important for the fetus.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay